Literature DB >> 28601358

C1q: A fresh look upon an old molecule.

Nicole M Thielens1, Francesco Tedesco2, Suzanne S Bohlson3, Christine Gaboriaud4, Andrea J Tenner5.   

Abstract

Originally discovered as part of C1, the initiation component of the classical complement pathway, it is now appreciated that C1q regulates a variety of cellular processes independent of complement activation. C1q is a complex glycoprotein assembled from 18 polypeptide chains, with a C-terminal globular head region that mediates recognition of diverse molecular structures, and an N-terminal collagen-like tail that mediates immune effector mechanisms. C1q mediates a variety of immunoregulatory functions considered important in the prevention of autoimmunity such as the enhancement of phagocytosis, regulation of cytokine production by antigen presenting cells, and subsequent alteration in T-lymphocyte maturation. Furthermore, recent advances indicate additional roles for C1q in diverse physiologic and pathologic processes including pregnancy, tissue repair, and cancer. Finally, C1q is emerging as a critical component of neuronal network refinement and homeostatic regulation within the central nervous system. This review summarizes the classical functions of C1q and reviews novel discoveries within the field.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Complement C1q; Neurobiology; Pregnancy; Tumor; Wound healing

Mesh:

Substances:

Year:  2017        PMID: 28601358      PMCID: PMC5582005          DOI: 10.1016/j.molimm.2017.05.025

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  158 in total

1.  Complement receptor type 1 (CR1, CD35) is a receptor for C1q.

Authors:  L B Klickstein; S F Barbashov; T Liu; R M Jack; A Nicholson-Weller
Journal:  Immunity       Date:  1997-09       Impact factor: 31.745

2.  Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin.

Authors:  B Brodsky-Doyle; K R Leonard; K B Reid
Journal:  Biochem J       Date:  1976-11       Impact factor: 3.857

3.  Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells.

Authors:  Manuel D Galvan; Deborah B Foreman; Erliang Zeng; John C Tan; Suzanne S Bohlson
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

4.  CD91 interacts with mannan-binding lectin (MBL) through the MBL-associated serine protease-binding site.

Authors:  Karen Duus; Nicole M Thielens; Monique Lacroix; Pascale Tacnet; Philippe Frachet; Uffe Holmskov; Gunnar Houen
Journal:  FEBS J       Date:  2010-11-05       Impact factor: 5.542

5.  Novel collectin/C1q receptor mediates mast cell activation and innate immunity.

Authors:  Brian T Edelson; Thomas P Stricker; Zhengzhi Li; S Kent Dickeson; Virginia L Shepherd; Samuel A Santoro; Mary M Zutter
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

6.  Decreased apopto-phagocytic gene expression in the macrophages of systemic lupus erythematosus patients.

Authors:  G Majai; E Kiss; T Tarr; G Zahuczky; Z Hartman; G Szegedi; L Fésüs
Journal:  Lupus       Date:  2013-11-27       Impact factor: 2.911

7.  Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.

Authors:  Hansen Lui; Jiasheng Zhang; Stefanie R Makinson; Michelle K Cahill; Kevin W Kelley; Hsin-Yi Huang; Yulei Shang; Michael C Oldham; Lauren Herl Martens; Fuying Gao; Giovanni Coppola; Steven A Sloan; Christine L Hsieh; Charles C Kim; Eileen H Bigio; Sandra Weintraub; Marek-Marsel Mesulam; Rosa Rademakers; Ian R Mackenzie; William W Seeley; Anna Karydas; Bruce L Miller; Barbara Borroni; Roberta Ghidoni; Robert V Farese; Jeanne T Paz; Ben A Barres; Eric J Huang
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

8.  C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production.

Authors:  Deborah A Fraser; Karntipa Pisalyaput; Andrea J Tenner
Journal:  J Neurochem       Date:  2009-11-16       Impact factor: 5.372

9.  Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression.

Authors:  Myoungsun Son; Betty Diamond; Bruce T Volpe; Cynthia B Aranow; Meggan C Mackay; Frances Santiago-Schwarz
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

10.  The human c1q globular domain: structure and recognition of non-immune self ligands.

Authors:  Christine Gaboriaud; Philippe Frachet; Nicole M Thielens; Gérard J Arlaud
Journal:  Front Immunol       Date:  2012-01-06       Impact factor: 7.561

View more
  69 in total

1.  Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.

Authors:  Alejandra Bosco; Sarah R Anderson; Kevin T Breen; Cesar O Romero; Michael R Steele; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Stephen Tomlinson; Monica L Vetter
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

2.  Cigarette smoke-induced reduction of C1q promotes emphysema.

Authors:  Xiaoyi Yuan; Cheng-Yen Chang; Ran You; Ming Shan; Bon Hee Gu; Matthew C Madison; Gretchen Diehl; Sarah Perusich; Li-Zhen Song; Lorraine Cornwell; Roger D Rossen; Rick Wetsel; Rajapakshe Kimal; Cristian Coarfa; Holger K Eltzschig; David B Corry; Farrah Kheradmand
Journal:  JCI Insight       Date:  2019-05-21

3.  HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis.

Authors:  Tianye Liu; Alec Xiang; Travis Peng; Amanda C Doran; Kevin J Tracey; Betsy J Barnes; Ira Tabas; Myoungsun Son; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

4.  Ocular Dominance Plasticity in Binocular Primary Visual Cortex Does Not Require C1q.

Authors:  Christina A Welsh; Céleste-Élise Stephany; Richard W Sapp; Beth Stevens
Journal:  J Neurosci       Date:  2019-12-04       Impact factor: 6.167

Review 5.  The Complement System and Preeclampsia.

Authors:  Jean F Regal; Richard M Burwick; Sherry D Fleming
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

6.  HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q.

Authors:  Jennetta W Hammond; Wen Q Qiu; Daniel F Marker; Jeffrey M Chamberlain; Will Greaves-Tunnell; Matthew J Bellizzi; Shao-Ming Lu; Harris A Gelbard
Journal:  Glia       Date:  2018-10-16       Impact factor: 7.452

Review 7.  Utilization of Biomarkers in Lupus Nephritis.

Authors:  Dawn J Caster; David W Powell
Journal:  Adv Chronic Kidney Dis       Date:  2019-09       Impact factor: 3.620

8.  Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway.

Authors:  Victoria Espericueta; Ayla O Manughian-Peter; Isabelle Bally; Nicole M Thielens; Deborah A Fraser
Journal:  Mol Immunol       Date:  2019-11-15       Impact factor: 4.407

Review 9.  Recent advances into the role of pattern recognition receptors in transplantation.

Authors:  Hrishikesh S Kulkarni; Davide Scozzi; Andrew E Gelman
Journal:  Cell Immunol       Date:  2020-03-07       Impact factor: 4.868

Review 10.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Authors:  Federica Defendi; Nicole M Thielens; Giovanna Clavarino; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.